1. Home
  2. ARQQ vs FTRE Comparison

ARQQ vs FTRE Comparison

Compare ARQQ & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQQ
  • FTRE
  • Stock Information
  • Founded
  • ARQQ 2017
  • FTRE 1996
  • Country
  • ARQQ United Kingdom
  • FTRE United States
  • Employees
  • ARQQ N/A
  • FTRE N/A
  • Industry
  • ARQQ Computer Software: Prepackaged Software
  • FTRE Medical Specialities
  • Sector
  • ARQQ Technology
  • FTRE Health Care
  • Exchange
  • ARQQ Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • ARQQ 531.6M
  • FTRE 468.1M
  • IPO Year
  • ARQQ N/A
  • FTRE N/A
  • Fundamental
  • Price
  • ARQQ $36.54
  • FTRE $5.01
  • Analyst Decision
  • ARQQ Strong Buy
  • FTRE Hold
  • Analyst Count
  • ARQQ 1
  • FTRE 11
  • Target Price
  • ARQQ $52.00
  • FTRE $16.00
  • AVG Volume (30 Days)
  • ARQQ 1.3M
  • FTRE 2.6M
  • Earning Date
  • ARQQ 05-22-2025
  • FTRE 08-11-2025
  • Dividend Yield
  • ARQQ N/A
  • FTRE N/A
  • EPS Growth
  • ARQQ N/A
  • FTRE N/A
  • EPS
  • ARQQ 0.48
  • FTRE N/A
  • Revenue
  • ARQQ $241,000.00
  • FTRE $2,685,600,000.00
  • Revenue This Year
  • ARQQ $1,818.77
  • FTRE N/A
  • Revenue Next Year
  • ARQQ N/A
  • FTRE $0.93
  • P/E Ratio
  • ARQQ $75.25
  • FTRE N/A
  • Revenue Growth
  • ARQQ N/A
  • FTRE N/A
  • 52 Week Low
  • ARQQ $3.72
  • FTRE $3.97
  • 52 Week High
  • ARQQ $52.79
  • FTRE $28.41
  • Technical
  • Relative Strength Index (RSI)
  • ARQQ 55.94
  • FTRE 47.71
  • Support Level
  • ARQQ $34.50
  • FTRE $4.36
  • Resistance Level
  • ARQQ $41.40
  • FTRE $5.61
  • Average True Range (ATR)
  • ARQQ 3.86
  • FTRE 0.38
  • MACD
  • ARQQ -0.62
  • FTRE -0.00
  • Stochastic Oscillator
  • ARQQ 37.75
  • FTRE 51.37

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: